Afghanistan vs Yemen: Share of children with symptoms of a respiratory infection who received antibiotics
Afghanistan
63.5%
in 2018
Yemen
63.6%
in 2018
Afghanistan rank
32nd
Yemen rank
31st
Share of children with symptoms of a respiratory infection who received antibiotics over time
- Afghanistan
- Yemen
How they compare
Yemen currently reports 63.6% against 63.5% in Afghanistan, a difference of 0.1%.
The two have swapped places 3 times across 19 shared years of data; in 2000 it was Afghanistan ahead.
Afghanistan ranks 32nd and Yemen ranks 31st of 132 countries.
Afghanistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 65.5% | 42.6% | 22.9% | Afghanistan |
| 2010s | 64.7% | 64.6% | 0.1% | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of children with symptoms of a respiratory infection who received antibiotics, Afghanistan or Yemen?
- Yemen, at 63.6% against 63.5% in Afghanistan as of 2018.
- What is the difference in share of children with symptoms of a respiratory infection who received antibiotics between Afghanistan and Yemen?
- 0.1%, with Yemen ahead.
- How many years of comparable data are there for Afghanistan and Yemen?
- 19 years are reported by both, from 2000 to 2018.
- How do Afghanistan and Yemen rank globally for share of children with symptoms of a respiratory infection who received antibiotics?
- Afghanistan ranks 32nd and Yemen ranks 31st of 132 countries.
- Where does this data come from?
- Browne AJ et al. (2021) – processed by Our World in Data, published as Share of children with symptoms of a respiratory infection who received antibiotics. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The caregiver reported share of children under five years old, with symptoms of lower respiratory tract infection, who received antibiotics for this illness.